Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2023

Genmab — November 2023

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #1422

    Renten bliver normalt sænket meget hvis der er recession. En recession er jo tegn på økonomien går ad H til. Typisk vil en recession være årsagen til, at obligationskurserne stiger – og renterne falder meget – da det får centralbanken til at sænke renten og stimulere økonomien, mens investorerne søger sikker havn i statsobligationerne.

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #1423

      Børsen kl 10. Genmab partner falder 17 % efter fejlet forsøg.

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1424

        yea... another day another biotech getting slammed...

        1 Reply Last reply
        0
        • T Offline
          T Offline
          Teller
          wrote on sidst redigeret af
          #1425

          Har Genmab overhovedet del i deres fejlede bløder medicin?

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #1426

            no, not at all

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1427

              Novartis approximates Kesimpta Peak sales at $4bn in their investor presentation https://www.novartis.com/sites/novartiscom/files/novartis-investors-r-d-day-2023.pdf

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1428

                Genmab A/S (NASDAQ:GMAB) Stock Rating Reaffirmed by HC Wainwright -"buy" rating restated by stock analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They presently have a $49.00 target price

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Klarussen
                  wrote on sidst redigeret af
                  #1429

                  Hvis den gik 3% ned i går på en "hold" anbefaling, så burde det her da kunne løfte den med et kursmål sv.t. 3332 kr.

                  1 Reply Last reply
                  0
                  • W Offline
                    W Offline
                    w
                    wrote on sidst redigeret af
                    #1430

                    Når der først er gået sur røv i en aktie, så
                    ser det svært ud

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #1431

                      Tror ikke fib 61,8 holder her. Tror vi skal have lukket det gap i 2035 imorgen. Så er vi også klar til ny op-tur frem mod ASH.

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #1432

                        3rd attempt for the German 10y bund yield to break below the 2.50% level this month; hopefully that can give us a bit of headwind...

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #1433

                          Tak EL (11:30) - Kesimpta fylder efterhånden en del i værdiansættelsen af Genmab.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1434

                            FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              Klarussen
                              wrote on sidst redigeret af
                              #1435

                              E L: can you enlighten us novices to the importance of this information in regard to Genmab?

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                Klarussen
                                wrote on sidst redigeret af
                                #1436

                                @w 15:50: spot on, gælder iøvrigt for mange andre fohold i livet end aktier

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #1437

                                  https://firstwordpharma.com/story/5804477?from=article For Genmab er det Carvykti der er interessant. Er af JNJ slået op til noget stort i myeloma - dara konkurrent. Så dette er meget vigtig for Genmab.

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    Klarussen
                                    wrote on sidst redigeret af
                                    #1438

                                    Tak Solsen

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #1439

                                      Ikke så heldigt hvis en kræftbehandling er kræftfremkaldende.

                                      1 Reply Last reply
                                      0
                                      • T Offline
                                        T Offline
                                        Teller
                                        wrote on sidst redigeret af
                                        #1440

                                        "FDA is investigating the identified risk of T-cell malignancy with serious outcomes, including hospitalisation and death, and is evaluating the need for regulatory action"

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #1441

                                          Jamen, hvis deres store "Dara-dræber" fejler, så må de nok hellere byde på Genmab.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper